Radiant Innovation (3373) - Net Assets

Latest as of June 2026: NT$787.02 Million TWD ≈ $24.80 Million USD

Based on the latest financial reports, Radiant Innovation (3373) has net assets worth NT$787.02 Million TWD (≈ $24.80 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$859.52 Million ≈ $27.08 Million USD) and total liabilities (NT$72.50 Million ≈ $2.28 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Radiant Innovation's equity deployed to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$787.02 Million
% of Total Assets 91.57%
Annual Growth Rate 2.14%
5-Year Change -25.66%
10-Year Change N/A
Growth Volatility 37.41

Radiant Innovation - Net Assets Trend (2017–2025)

This chart illustrates how Radiant Innovation's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 3373 market cap overview.

Annual Net Assets for Radiant Innovation (2017–2025)

The table below shows the annual net assets of Radiant Innovation from 2017 to 2025. Also explore 3373 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 NT$793.80 Million
≈ $25.01 Million
-8.33%
2024-12-31 NT$865.89 Million
≈ $27.28 Million
-6.50%
2023-12-31 NT$926.06 Million
≈ $29.18 Million
-9.34%
2022-12-31 NT$1.02 Billion
≈ $32.18 Million
-4.34%
2021-12-31 NT$1.07 Billion
≈ $33.64 Million
-20.71%
2020-12-31 NT$1.35 Billion
≈ $42.43 Million
+104.44%
2019-12-31 NT$658.75 Million
≈ $20.75 Million
-1.11%
2018-12-31 NT$666.12 Million
≈ $20.99 Million
-0.57%
2017-12-31 NT$669.96 Million
≈ $21.11 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Radiant Innovation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 18.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings NT$94.83 Million 11.95%
Other Components NT$698.97 Million 88.05%
Total Equity NT$793.80 Million 100.00%

Radiant Innovation Competitors by Market Cap

The table below lists competitors of Radiant Innovation ranked by their market capitalization.

Company Market Cap
Nextplat Corp
NASDAQ:NXPL
$23.93 Million
Eutilex.Co.Ltd
KQ:263050
$23.94 Million
Conduril - Engenharia S.A
LS:CDU
$23.94 Million
Amanet Management & Systems Ltd
TA:AMAN
$23.94 Million
KebNi AB (publ)
ST:KEBNI-B
$23.93 Million
WITTED MEGACORP OYJ EO 1
F:8OS
$23.93 Million
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904
$23.93 Million
KB Autosys Co. Ltd
KQ:024120
$23.93 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Radiant Innovation's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 865,894,000 to 793,805,000, a change of -72,089,000 (-8.3%).
  • Net loss of 60,448,000 reduced equity.
  • Other factors decreased equity by 11,641,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income NT$-60.45 Million -7.61%
Other Changes NT$-11.64 Million -1.47%
Total Change NT$- -8.33%

Book Value vs Market Value Analysis

This analysis compares Radiant Innovation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.96x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 NT$15.48 NT$15.95 x
2018-12-31 NT$15.39 NT$15.95 x
2019-12-31 NT$15.22 NT$15.95 x
2020-12-31 NT$31.11 NT$15.95 x
2021-12-31 NT$24.67 NT$15.95 x
2022-12-31 NT$23.60 NT$15.95 x
2023-12-31 NT$19.45 NT$15.95 x
2024-12-31 NT$18.18 NT$15.95 x
2025-12-31 NT$16.67 NT$15.95 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Radiant Innovation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -7.61%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -15.60%
  • • Asset Turnover: 0.45x
  • • Equity Multiplier: 1.09x
  • Recent ROE (-7.61%) is below the historical average (6.70%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 1.98% 1.72% 0.96x 1.20x NT$-53.71 Million
2018 2.14% 1.75% 1.02x 1.20x NT$-52.38 Million
2019 4.37% 3.66% 1.00x 1.19x NT$-37.11 Million
2020 54.68% 28.14% 1.36x 1.43x NT$601.67 Million
2021 10.53% 11.42% 0.79x 1.16x NT$5.69 Million
2022 2.81% 5.08% 0.51x 1.09x NT$-73.49 Million
2023 -5.27% -11.65% 0.43x 1.06x NT$-141.37 Million
2024 -3.30% -6.80% 0.45x 1.08x NT$-115.17 Million
2025 -7.61% -15.60% 0.45x 1.09x NT$-139.83 Million

Industry Comparison

This section compares Radiant Innovation's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $1,887,083,000
  • Average return on equity (ROE) among peers: 6.44%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Radiant Innovation (3373) NT$787.02 Million 1.98% 0.09x $23.93 Million
Hi-Clearance (1788) $3.00 Billion 11.98% 0.65x $179.54 Million
Wellell Inc (4106) $2.06 Billion 4.95% 0.52x $77.57 Million
Rossmax International Ltd (4121) $1.34 Billion 1.24% 0.71x $32.72 Million
United Orthopedic (4129) $3.59 Billion 10.69% 0.79x $250.36 Million
Dynamic Medical Technologies (4138) $1.46 Billion 7.93% 0.46x $67.81 Million
Ok Biotech Co Ltd (4155) $1.74 Billion 7.46% 0.46x $66.03 Million
Bioptik Technology (4161) $887.42 Million -3.80% 0.76x $41.93 Million
AViTA Corporation (4735) $838.11 Million 6.91% 0.42x $43.25 Million
TAIDOC TECHNOLOGY CORP (4736) $2.05 Billion 10.57% 0.48x $385.16 Million

About Radiant Innovation

TWO:3373 Taiwan Medical Devices
Market Cap
$23.93 Million
NT$759.52 Million TWD
Market Cap Rank
#24620 Global
#1528 in Taiwan
Share Price
NT$15.95
Change (1 day)
+0.95%
52-Week Range
NT$15.80 - NT$20.65
All Time High
NT$110.75
About

Radiant Innovation Inc. engages in the design and development of infrared technology products. It offers medical infrared thermometers, including infrared ear, non-contact forehead, and multi-function thermometers, as well as probe cover; industrial infrared thermometers; and CO2 monitors. Radiant Innovation Inc. was founded in 1989 and is headquartered in Hsinchu City, Taiwan.